Global Preventive Asthma Drugs Market 2011-2015
Global Preventive Asthma Drugs Market
Global Preventive Asthma Drugs Market
Description
TechNavio's analysts forecast the Global
Preventive Asthma Drugs market to grow at a CAGR of 4.5 percent over the
period 2011-2015. One of the key factors contributing to this market
growth is the increasing incidence of asthma. The Global Preventive
Asthma Drugs market has also been witnessing the trend of an increased
focus on contract manufacturing outsourcing. However, the increasing
generic competition could pose a challenge to the growth of this market.
TechNavio's report, the Global Preventive Asthma Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Preventive Asthma Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are AstraZeneca plc., GlaxoSmithKline plc., Merck & Co.Inc., Novartis AG
Key questions answered in this report:
What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
TechNavio's report, the Global Preventive Asthma Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Preventive Asthma Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are AstraZeneca plc., GlaxoSmithKline plc., Merck & Co.Inc., Novartis AG
Key questions answered in this report:
What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Key Offerings
04. Market Landscape
04.1 Global Preventive Asthma Drugs Market
Market Size and Forecast
04.2 Global Preventive Asthma Drugs Market by Product Segmentation
04.3 Five Forces Analysis
05. Geographical Segmentation
06. Rate of Incidence and Prevalence
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 AstraZeneca plc
Business Overview
Key Information
SWOT Analysis
14.2 GlaxoSmithKline plc
Business Overview
Key Information
SWOT Analysis
14.3 Merck & Co. Inc.
Business Overview
Key Information
SWOT Analysis
14.4 Novartis AG
Business Overview
Key Information
SWOT Analysis
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Preventive Asthma Drugs Market 2011-2015 (US$ billion)
Exhibit 2: Global Preventive Asthma Drugs Market by Product Segmentation
Exhibit 3: Global Preventive Asthma Drugs Market by Geographical Segmentation 2011
Exhibit 4: Global Preventive Asthma Drugs Market by Vendor Segmentation 2011
02. Introduction
03. Market Coverage
Market Overview
Key Offerings
04. Market Landscape
04.1 Global Preventive Asthma Drugs Market
Market Size and Forecast
04.2 Global Preventive Asthma Drugs Market by Product Segmentation
04.3 Five Forces Analysis
05. Geographical Segmentation
06. Rate of Incidence and Prevalence
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 AstraZeneca plc
Business Overview
Key Information
SWOT Analysis
14.2 GlaxoSmithKline plc
Business Overview
Key Information
SWOT Analysis
14.3 Merck & Co. Inc.
Business Overview
Key Information
SWOT Analysis
14.4 Novartis AG
Business Overview
Key Information
SWOT Analysis
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Preventive Asthma Drugs Market 2011-2015 (US$ billion)
Exhibit 2: Global Preventive Asthma Drugs Market by Product Segmentation
Exhibit 3: Global Preventive Asthma Drugs Market by Geographical Segmentation 2011
Exhibit 4: Global Preventive Asthma Drugs Market by Vendor Segmentation 2011
To Browse All Reports: http://www.marketresearchreports.biz/
No comments:
Post a Comment